MICROCHIP TECHNOLOGY INCMCHP

In a brutal demonstration of semiconductor cyclicality, Microchip Technology saw its quarterly net sales collapse by 45.8% year-over-year to $1.24 billion in the first quarter of FY2025. Despite this violent inventory correction, the central investment thesis hinges on the company's ability to defend its pricing power and maintain its strategic foothold in high-growth AI, data center, and automotive markets.

The company's long-term financial arc reflects a dramatic boom-and-bust cycle. While peak supply shortages drove an EPS of $2.27 in FY2022, the top-line trajectory saw annual net sales ultimately plummet from a high of $8.44 billion in FY2023 to just $4.71 billion by FY2026. To offset this severe demand shock, management aggressively restructured operations, notably shuttering its Tempe fabrication facility to unlock $90 million in annual cash savings. These operational contractions dragged full-year gross margins down to 57.7% in FY2026, a steep drop from the 68.1% high recorded in early FY2024. Yet, Microchip continued funding its innovation pipeline, pushing research and development spending up to 23.0% of net sales in FY2026.

The market consistently priced in a recovery well before the fundamentals bottomed. At the close of FY2025, investors awarded the company a $26.1 billion market capitalization despite a $-0.01 per-share net loss. By the end of FY2026, as sequential quarterly sales began rebounding, the stock traded at a closing price of $64.61, reflecting sustained confidence in the company's eventual cyclical normalization.